SCHEMBL11305647

SCHEMBL11305647

O=C(NO)c1ccc(N(c2ccc(F)cc2)C2CCNC2=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 8/20 0.41
▸ HDAC8 Q9BY41 7/20 0.41
▸ HDAC3 O15379 1/20 0.41
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ HDAC1 Q13547 4/20 0.38
▸ GPR6 P46095 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ ADAM17 P78536 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HDAC11 Q96DB2 1/20 0.37
▸ APOL1 O14791 1/20 0.37
▸ ALOX5 P09917 1/20 0.37
▸ KDM1A O60341 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11297375 0.89 HDAC8 (0.44) HDAC6HDAC8HDAC3NPC1HDAC1
SCHEMBL11302647 0.89 HDAC6 (0.43) HDAC6HDAC8NPC1HDAC1GPR6
SCHEMBL11301754 0.88 PSEN1 (0.42) HDAC6HDAC8HDAC1
SCHEMBL11300698 0.87 PSEN1 (0.36) HDAC6HDAC8HDAC1HDAC11
SCHEMBL11297394 0.86 HDAC6 (0.41) HDAC6HDAC8HDAC3NPC1RAB9A
SCHEMBL11296049 0.85 HDAC6 (0.45) HDAC6HDAC8NPC1RAB9AHDAC1
SCHEMBL11303268 0.85 ABL1 (0.37) HDAC6HDAC8HDAC3NPC1RAB9A
SCHEMBL11303351 0.85 HDAC6 (0.40) HDAC6HDAC8HDAC3HDAC1KDM4E
SCHEMBL11303328 0.84 HDAC8 (0.37) HDAC6HDAC8RAB9AHDAC1KDM4E
SCHEMBL11299083 0.84 HDAC6 (0.42) HDAC6HDAC8HDAC3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback